Grant: Project Grant
Ottawa Hospital Research Institute
$707,625.00
Defining the Caspase/CAD-Mediated Origin of Alveolar Rhabdomyosarcoma
EF 2017-18
Résumé
Tumours that develop in muscle are referred to as rhabdomyosarcoma. This is an exceptionally aggressive solid tumour that affects young children and treatment options are limited. One subtype of this cancer, alveolar rhabdomyosarcoma, is caused when two broken genes are repaired to create one gene with cancer causing properties. This phenomenon also occurs in many other cancer types, yet how these broken genes are formed remains unknown. In the current research plan we propose to identify how these broken genes are formed and what factors inside the cell prevent the formation of the rearranged cancer gene.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
370499
Name
Megeney Lynn A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Genetics
Projecttitle
Defining the Caspase/CAD-Mediated Origin of Alveolar Rhabdomyosarcoma
Programtype2
Operating Grants
Orgnameinp2
Ottawa Hospital Research Institute
Cihramount2
$707,625
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Caspase; Caspase Activated Dnase; Dna Damage; Dna Repair; Rhabdomyosarcoma
Abstract
Tumours that develop in muscle are referred to as rhabdomyosarcoma. This is an exceptionally aggressive solid tumour that affects young children and treatment options are limited. One subtype of this cancer, alveolar rhabdomyosarcoma, is caused when two broken genes are repaired to create one gene with cancer causing properties. This phenomenon also occurs in many other cancer types, yet how these broken genes are formed remains unknown. In the current research plan we propose to identify how these broken genes are formed and what factors inside the cell prevent the formation of the rearranged cancer gene.
Competitiondate
201709
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Megeney, Lynn A
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $707,625~ $0~